* For sale in the U.S.A only

INTENDED USE

Parvovirus B19 IgM (mu capture) Enzyme Immunoassay An in-vitro enzyme immunoassay for the detection of anti-Parvovirus B19 IgM antibodies in human serum and plasma.

ASSAY PRINCIPLE

The Biotrin International Parvovirus B19 IgM Enzyme Immunoassay is a mu-capture sandwich enzyme immunoassay for the detection of IgM class antibodies to Parvovirus B19 in human serum and plasma. Microassay wells are coated with a rabbit anti-human IgM. Total IgM antibodies in the serum or plasma will bind to the solid phase. Following a wash step, biotinylated purified Parvovirus B19 recombinant VP2 protein is added which binds to any human Parvovirus B19 IgM antibodies present. After another wash step, streptavidin peroxidase is added which binds to the biotinylated VP2 present. The whole complex is then detected by addition of substrate (TMB) which turns blue in the presence of peroxidase. A stable yellow end product is achieved by the addition of a stopping reagent.

Biotrin Parvovirus B19 IgM EIA (U.S.A FDA Cleared) Instructions for Use 

ORDERING INFORMATION